| 1 |
Anti-von willebrand factor nanobody |
Von Willebrand Factor Human |
- |
- |
- |
064 [1] 64 💬 |
| 2 |
Anti-von willebrand factor nanobody, caplacizumab |
Caplacizumab |
[1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
| 3 |
Anti-von willebrand factor nanobody, inn = caplacizumab |
Caplacizumab |
[1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
| 4 |
Caplacizumab (an anti-von willebrand factor nanobody alx-0081) |
Caplacizumab |
[1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
| 5 |
Caplacizumab (an anti-von willebrand factor nanobody) |
Caplacizumab |
[1] D11160 D11160 💬 |
VWF [1] VWF 💬 |
Complement and coagulation cascades [8] Complement and coagulation cascades, Coronavirus disease - COVID-19, ECM-receptor interaction, Focal adhesion, Human papillomavirus infection, Neutrophil extracellular trap formation, PI3K-Akt signaling pathway, Platelet activation |
064 [1] 64 💬 |
| 6 |
Human coagulation factor viii / von willebrand factor |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
| 7 |
Human coagulation factor viii associated with von willebrand factor (vwf) |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
| 8 |
Human coagulation factor viii, von willebrand factor complex |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
| 9 |
Human von willebrand factor |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 10 |
Human von willebrand factor (vwf) and coagulation factor viii (fviii) |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 11 |
Recombinant coagulation fviii fc – von willebrand factor – xten fusion protein |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 12 |
Recombinant human coagulation factor viii fc - von willebrand factor - xten fusion protein |
Antihemophilic factor human |
- |
- |
- |
288 [1] 288 💬 |
| 13 |
Recombinant human von willebrand factor |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 14 |
Recombinant von willebrand factor |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 15 |
Recombinant von willebrand factor (rvwf) |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 16 |
Recombinant von willebrand factor 1300iu |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 17 |
Recombinant von willebrand factor 650iu |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 18 |
Recombinant von willebrand factor : recombinant fviii (rvwf:rfviii) |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 19 |
Recomibnant human von willebrand factor |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 20 |
Von willebrand factor |
Von Willebrand Factor Human |
- |
- |
- |
064 [2] 64, 288 💬 |
| 21 |
Von willebrand factor (recombinant) |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 22 |
Von willebrand factor and coagulation factor viii in combination |
Beroctocog alfa |
- |
- |
- |
288 [1] 288 💬 |
| 23 |
Von willebrand factor antigen |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 24 |
Von willebrand factor ristocetin cofactor |
Von Willebrand Factor Human |
- |
- |
- |
288 [1] 288 💬 |
| 25 |
Vonicog alfa |
Vonicog Alfa |
[1] D08681 D08681 💬 |
- |
- |
288 [1] 288 💬 |